Shigella-Controlled Human Infection Models: Current and Future Perspectives.
Clarkson, KA; Porter, CK; Talaat, KR; Kapulu, MC; Chen, WH; Frenck, RW; Bourgeois, AL; Kaminski, RW; Martin, LB.
Current Topics in Microbiology and Immunology.
2022.
Editorial.
Frenck, RW.
Current Opinion in Pediatrics.
2022;
34:117-118.
Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al.
New England Journal of Medicine.
2022;
386:1046-1057.
A site assessment tool for inpatient controlled human infection models for enteric disease pathogens.
Porter, CK; Detizio, KJ; Maier, N; Testa, KJ; Talaat, KR; Chen, WH; Lyon, CE; Gutierrez, RL; Frenck, R; Isidean, SD; et al.
Clinical Trials.
2022;
19:116-118.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
Walter, EB; Talaat, KR; Sabhar, C; Gurtman, A; Lockhart, S; Paulsen, GC; Barnett, ED; Muñoz, FM; Maldonado, Y; Pahud, BA; et al.
New England Journal of Medicine.
2022;
386:35-46.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults 18 Years and Older.
Essink, B; Sabharwal, C; Cannon, K; Frenck, R; Lal, H; Xu, X; Sundaraiyer, V; Peng, Y; Moyer, L; Pride, MW; et al.
Clinical Infectious Diseases.
2021.
Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
Venkatesan, MM; Ballou, C; Barnoy, S; McNeal, M; El-Khorazaty, J; Frenck, R; Baqar, S.
PLoS ONE.
2021;
16.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Zenilman, J; Belshe, R; Edwards, K; Self, S; Stanberry, L; Newell, T; Hunt, S; Jack, P; Adams, G; Ali-Abadi, N; et al.
New England Journal of Medicine.
2021;
385:1761-1773.
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Falsey, AR; Frenck, RW; Walsh, EE; Kitchin, N; Absalon, J; Gurtman, A; Lockhart, S; Bailey, R; Swanson, KA; Xu, X; et al.
New England Journal of Medicine.
2021;
385:1627-1629.
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report.
Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al.
2021.